HER2-overexpressing breast cancer xenografts amplify FGFR signaling upon acquisition of resistance to dual blockade with trastuzumab and lapatinib

被引：0
|
作者：
Garrett, Joan T. [1 ]
Becker, Jennifer [1 ]
Estrada, Monica Valeria [1 ]
Arteaga, Carlos L. [1 ]
机构：
[1] Vanderbilt Univ, Nashville, TN 37235 USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-LB-212
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-212
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Downregulation of Erbin in Her2-overexpressing breast cancer cells promotes cell migration and induces trastuzumab resistance
    Liu, Dan
    Shi, Ming
    Duan, Chenyang
    Chen, Hongyu
    Hu, Yabin
    Yang, Zhengyan
    Duan, Huijun
    Guo, Ning
    MOLECULAR IMMUNOLOGY, 2013, 56 (1-2) : 104 - 112
  • [32] Trastuzumab-targeted gene delivery to Her2-overexpressing breast cancer cells
    Mann, K.
    Kullberg, M.
    CANCER GENE THERAPY, 2016, 23 (07) : 221 - 228
  • [33] A phase II study of lapatinib and bevacizumab as treatment for HER2-overexpressing metastatic breast cancer
    Hope S. Rugo
    A. Jo Chien
    Sandra X. Franco
    Alison T. Stopeck
    Alexa Glencer
    Soumi Lahiri
    Michael C. Arbushites
    Janet Scott
    John W. Park
    Clifford Hudis
    Ben Nulsen
    Maura N. Dickler
    Breast Cancer Research and Treatment, 2012, 134 : 13 - 20
  • [34] A phase II study of lapatinib and bevacizumab as treatment for HER2-overexpressing metastatic breast cancer
    Rugo, Hope S.
    Chien, A. Jo
    Franco, Sandra X.
    Stopeck, Alison T.
    Glencer, Alexa
    Lahiri, Soumi
    Arbushites, Michael C.
    Scott, Janet
    Park, John W.
    Hudis, Clifford
    Nulsen, Ben
    Dickler, Maura N.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (01) : 13 - 20
  • [35] Autophagy Stimulates Apoptosis in HER2-Overexpressing Breast Cancers Treated by Lapatinib
    Zhu, Xingmei
    Wu, Lin
    Qiao, Hongyu
    Han, Tenglong
    Chen, Suning
    Liu, Xueying
    Jiang, Ru
    Wei, Yifang
    Feng, Dayun
    Zhang, Yuan
    Ma, Yongzheng
    Zhang, Shengyong
    Zhang, Jian
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2013, 114 (12) : 2643 - 2653
  • [36] Overcoming trastuzumab resistance in HER2-overexpressing breast cancer by utilizing PHB2, a tumor suppressor of multiple resistance pathways
    Yoshimaru, Tetsuro
    Matsushita, Yosuke
    Sasa, Mitsunori
    Miyoshi, Yasuo
    Katagiri, Toyomasa
    CANCER RESEARCH, 2018, 78 (13)
  • [37] Taxanes Plus Trastuzumab Compared To Oral Vinorelbine Plus Trastuzumab in HER2-Overexpressing Metastatic Breast Cancer
    Bergen, Elisabeth
    Berghoff, Anna S.
    Rudas, Margaretha
    Dubsky, Peter
    De Vries, Catharina
    Sattlberger, Claudia
    Mader, Robert M.
    Zagouri, Flora
    Sparber, Cornelia
    Fitzal, Florian
    Gnant, Michael
    Rottenfusser, Andrea
    Zielinski, Christoph C.
    Preusser, Matthias
    Steger, Guenther G.
    Bartsch, Rupert
    BREAST CARE, 2014, 9 (05) : 344 - 348
  • [38] Pulsed-laser irradiation of multifunctional gold nanoshells to overcome trastuzumab resistance in HER2-overexpressing breast cancer
    Toni Nunes
    Thomas Pons
    Xue Hou
    Khanh Van Do
    Benoît Caron
    Marthe Rigal
    Mélanie Di Benedetto
    Bruno Palpant
    Christophe Leboeuf
    Anne Janin
    Guilhem Bousquet
    Journal of Experimental & Clinical Cancer Research, 38
  • [39] Pulsed-laser irradiation of multifunctional gold nanoshells to overcome trastuzumab resistance in HER2-overexpressing breast cancer
    Nunes, Toni
    Pons, Thomas
    Hou, Xue
    Khanh Van Do
    Caron, Benoit
    Rigal, Marthe
    Di Benedetto, Melanie
    Palpant, Bruno
    Leboeuf, Christophe
    Janin, Anne
    Bousquet, Guilhem
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (1)
  • [40] Application of intrathecal trastuzumab for treatment of meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer
    Shojima, K.
    Suzuki, E.
    Saito, K.
    Sekine, S.
    Kitagawa, D.
    Aruga, T.
    Saji, S.
    Kuroi, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345